Insider · CIK 0001874962

Appelhans Dannielle

Reports to the SEC for 3 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001874962

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-01	HALOHALOZYME THERAPEUTICS, INC.A Award	Director	AAward	+1,161 sh	—	—	1,161
2026-09-01	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockA Award	Director	AAward	+1,778 sh	—	—	1,778
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,840 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,000 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co.U Disposition from Tender	Director	UDisposition from Tender	−736 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co.U Disposition from Tender	Director	UDisposition from Tender	−1,263 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2025-06-04	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2024-06-06	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+60K sh	—	—	60,000
2023-12-08	GBIOGeneration Bio Co.P Purchase	Director	PPurchase	+637 sh	$1.82	+$1,159.34	12,637
2023-12-08	GBIOGeneration Bio Co.P Purchase	Director	PPurchase	+7,363 sh	$1.79	+$13.2K	7,363
2023-12-04	GBIOGeneration Bio Co.P Purchase	Director	PPurchase	+12K sh	$1.50	+$18K	12,000
2023-06-08	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-02-24	Rubius Therapeutics, Inc.S Sale	CEO and President	SSale	−10.4K sh	$0.13	−$1,323.049	0
2023-02-01	Rubius Therapeutics, Inc.S Sale	CEO and President	SSale	−3,878 sh	$0.25	−$969.5	10,385
2023-01-31	Rubius Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	CEO and President	MExercise/Conversion	−7,500 sh	—	—	22,500
2023-01-31	Rubius Therapeutics, Inc.M Exercise/Conversion	CEO and President	MExercise/Conversion	+7,500 sh	—	—	14,263
2022-08-10	Rubius Therapeutics, Inc.S Sale	CEO and President	SSale	−5,737 sh	$0.80	−$4,589.6	6,763
2022-08-09	Rubius Therapeutics, Inc.M Exercise/Conversion	CEO and President	MExercise/Conversion	+12.5K sh	—	—	12,500
2022-08-09	Rubius Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	CEO and President	MExercise/Conversion	−12.5K sh	—	—	37,500
2022-07-15	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+38.4K sh	—	—	38,400
2022-01-31	Rubius Therapeutics, Inc.Stock Option (Right to Buy)A Award	CEO and President	AAward	+125K sh	—	—	125,000
2022-01-31	Rubius Therapeutics, Inc.Restricted Stock UnitsA Award	CEO and President	AAward	+30K sh	—	—	30,000
2021-08-31	Rubius Therapeutics, Inc.Restricted Stock UnitsA Award	CEO and President	AAward	+50K sh	—	—	50,000
2021-08-31	Rubius Therapeutics, Inc.Stock Option (Right to Buy)A Award	CEO and President	AAward	+150K sh	—	—	150,000

Recent filings

Accepted (ET)
Sep 24
Appelhans Dannielle0001159036-26-000117
SEC(opens sec.gov)
Feb 94
Appelhans Dannielle0001104659-26-012182
SEC(opens sec.gov)
Jun 64
Appelhans Dannielle0001415889-25-015959
SEC(opens sec.gov)
Jun 104
Appelhans Dannielle0001415889-24-016179
SEC(opens sec.gov)
Dec 114
Appelhans Dannielle0001415889-23-016186
SEC(opens sec.gov)
Dec 64
Appelhans Dannielle0001415889-23-015929
SEC(opens sec.gov)
Jun 124
Appelhans Dannielle0001415889-23-009604
SEC(opens sec.gov)
Feb 274
Appelhans Dannielle0001104659-23-026139
SEC(opens sec.gov)
Feb 14
Appelhans Dannielle0001104659-23-009464
SEC(opens sec.gov)
Aug 124
Appelhans Dannielle0001709401-22-000016
SEC(opens sec.gov)

Companies

Address

C/O HALOZYME THERAPEUTICS, INC. 12390 EL CAMINO REAL

SAN DIEGO, CA, 92130